Protection against homologous influenza challenge by genetic immunization with SFV-RNA encoding Flu-HA.
Dalemans
W
W
SmithKline Beecham Biologicals, Rixensart, Belgium.
Delers
A
A
Delmelle
C
C
Denamur
F
F
Meykens
R
R
Thiriart
C
C
Veenstra
S
S
Francotte
M
M
Bruck
C
C
Cohen
J
J
D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D005822:Genetic Vectors; D019267:Hemagglutinin Glycoproteins, Influenza Virus; D006389:Hemagglutinins, Viral / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*; D007117:Immunization, Secondary; D009980:Influenza A virus / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000276:immunology; D007273:Injections, Intramuscular; D051379:Mice; D009976:Orthomyxoviridae Infections / Q000276:immunology / Q000517:prevention & control*; D012313:RNA / Q000235:genetics*; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis / Q000276:immunology*; D012137:Respiratory System / Q000821:virology; D014611:Vaccination; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology
D000914:Antibodies, Viral; D019267:Hemagglutinin Glycoproteins, Influenza Virus; D006389:Hemagglutinins, Viral; D007252:Influenza Vaccines; C039919:RNA, recombinant; D011993:Recombinant Fusion Proteins; D014614:Vaccines, Synthetic; D012313:RNA